BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 23237916)

  • 21. Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System.
    Rajda C; Majláth Z; Pukoli D; Vécsei L
    Int J Mol Sci; 2015 Aug; 16(8):18270-82. PubMed ID: 26287161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites.
    Moroni F
    Eur J Pharmacol; 1999 Jun; 375(1-3):87-100. PubMed ID: 10443567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies.
    Pathak S; Nadar R; Kim S; Liu K; Govindarajulu M; Cook P; Watts Alexander CS; Dhanasekaran M; Moore T
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kynurenines in neurodegenerative disorders: therapeutic consideration.
    Klivényi P; Toldi J; Vécsei L
    Adv Exp Med Biol; 2004; 541():169-83. PubMed ID: 14977214
    [No Abstract]   [Full Text] [Related]  

  • 25. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.
    Zádori D; Klivényi P; Plangár I; Toldi J; Vécsei L
    J Cell Mol Med; 2011 Apr; 15(4):701-17. PubMed ID: 21155972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health.
    Cervenka I; Agudelo LZ; Ruas JL
    Science; 2017 Jul; 357(6349):. PubMed ID: 28751584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nature Reviews Drug Discovery: editorial article of neuroscientists from Szeged about kynurenine (IF: 33.078)].
    Vécsei L
    Ideggyogy Sz; 2014 Jan; 67(1-2):70. PubMed ID: 24654450
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design.
    Tajti J; Majlath Z; Szok D; Csati A; Toldi J; Fulop F; Vecsei L
    Curr Pharm Des; 2015; 21(17):2250-8. PubMed ID: 25557633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The kynurenine pathway: a finger in every pie.
    Savitz J
    Mol Psychiatry; 2020 Jan; 25(1):131-147. PubMed ID: 30980044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous kynurenines as targets for drug discovery and development.
    Stone TW; Darlington LG
    Nat Rev Drug Discov; 2002 Aug; 1(8):609-20. PubMed ID: 12402501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kynurenine Is a Cerebrospinal Fluid Biomarker for Bacterial and Viral Central Nervous System Infections.
    Sühs KW; Novoselova N; Kuhn M; Seegers L; Kaever V; Müller-Vahl K; Trebst C; Skripuletz T; Stangel M; Pessler F
    J Infect Dis; 2019 Jun; 220(1):127-138. PubMed ID: 30721966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.
    Tanaka M; Toldi J; Vécsei L
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery.
    Khan JA; Forouhar F; Tao X; Tong L
    Expert Opin Ther Targets; 2007 May; 11(5):695-705. PubMed ID: 17465726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.
    Cuartero MI; de la Parra J; García-Culebras A; Ballesteros I; Lizasoain I; Moro MÁ
    Curr Pharm Des; 2016; 22(8):1060-73. PubMed ID: 25248805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease.
    Majewski M; Kozlowska A; Thoene M; Lepiarczyk E; Grzegorzewski WJ
    J Physiol Pharmacol; 2016 Feb; 67(1):3-19. PubMed ID: 27010891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An exploratory study of the interplay between decreased concentration of tryptophan, accumulation of kynurenines, and inflammatory arthritis.
    Kolodziej L
    IUBMB Life; 2012 Dec; 64(12):983-7. PubMed ID: 23124849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging role for kynurenines in metabolic pathologies.
    Liu JJ; Movassat J; Portha B
    Curr Opin Clin Nutr Metab Care; 2019 Jan; 22(1):82-90. PubMed ID: 30407222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kynurenine metabolism in central nervous system in experimental chronic renal failure.
    Topczewska-Bruns J; Pawlak D; Tankiewicz A; Chabielska E; Buczko W
    Adv Exp Med Biol; 2003; 527():177-82. PubMed ID: 15206730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.